DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $112,678,000 | -67.8% | 370,120 | -71.6% | 0.48% | -67.5% |
| Q2 2021 | $349,519,000 | +70.1% | 1,302,423 | +42.7% | 1.48% | +73.1% |
| Q1 2021 | $205,462,000 | -30.4% | 912,831 | -31.3% | 0.85% | -36.5% |
| Q4 2020 | $295,103,000 | -6.3% | 1,328,454 | -9.1% | 1.34% | -33.3% |
| Q3 2020 | $314,824,000 | +134.4% | 1,462,055 | +92.5% | 2.02% | +127.4% |
| Q2 2020 | $134,304,000 | +82.4% | 759,505 | +42.7% | 0.89% | +59.0% |
| Q1 2020 | $73,642,000 | -32.6% | 532,062 | -25.3% | 0.56% | +5.9% |
| Q4 2019 | $109,308,000 | -48.2% | 712,198 | -51.3% | 0.53% | -56.1% |
| Q3 2019 | $211,207,000 | -26.8% | 1,462,350 | -27.5% | 1.20% | -32.9% |
| Q2 2019 | $288,451,000 | -48.4% | 2,018,272 | -52.3% | 1.79% | -9.6% |
| Q1 2019 | $558,562,000 | +280.2% | 4,230,876 | +197.0% | 1.98% | +39.2% |
| Q4 2018 | $146,905,000 | -58.3% | 1,424,601 | -56.1% | 1.42% | +17.2% |
| Q3 2018 | $352,696,000 | +171.6% | 3,245,878 | +146.6% | 1.21% | +65.5% |
| Q2 2018 | $129,863,000 | +8.9% | 1,316,003 | +8.0% | 0.73% | +22.8% |
| Q1 2018 | $119,293,000 | -34.4% | 1,218,395 | -37.8% | 0.60% | -40.6% |
| Q4 2017 | $181,791,000 | +7.9% | 1,958,533 | -0.1% | 1.00% | -5.7% |
| Q3 2017 | $168,519,000 | +41.4% | 1,959,530 | +38.1% | 1.07% | +22.4% |
| Q2 2017 | $119,164,000 | +2.3% | 1,418,625 | +4.8% | 0.87% | -5.2% |
| Q1 2017 | $116,462,000 | +7937.4% | 1,354,210 | +7117.4% | 0.92% | +2864.5% |
| Q4 2013 | $1,449,000 | – | 18,763 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |